|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Med_Immune
gptkb:Alexion_Pharmaceuticals
|
|
gptkbp:awards
|
Innovation Award 2020
Best Workplaces 2020
Top Employer UK 2021
Global Health Partner of the Year 2021
|
|
gptkbp:ceo
|
gptkb:Pascal_Soriot
|
|
gptkbp:clinical_trial
|
gptkb:drug
cancer treatments
respiratory diseases
diabetes treatments
|
|
gptkbp:community_engagement
|
research funding
education programs
volunteer programs
public health campaigns
healthcare access initiatives
|
|
gptkbp:employees
|
over 70,000
|
|
gptkbp:founded
|
gptkb:1999
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_England
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Astra Zeneca UK Limited
|
|
gptkbp:industry
|
gptkb:drug
|
|
gptkbp:parent_company
|
gptkb:temple
|
|
gptkbp:partnership
|
gptkb:GSK
gptkb:Oxford_University
gptkb:University_of_Cambridge
|
|
gptkbp:products
|
medications
|
|
gptkbp:research_focus
|
oncology
immunology
cardiovascular
respiratory
|
|
gptkbp:revenue
|
$37 billion (2020)
|
|
gptkbp:subsidiary
|
gptkb:Astra_Zeneca_AB
gptkb:Astra_Zeneca_Canada_Inc.
gptkb:Astra_Zeneca_PLC
gptkb:Astra_Zeneca_Pharmaceuticals_LP
|
|
gptkbp:sustainability_initiatives
|
diversity and inclusion programs
water conservation efforts
sustainable sourcing
carbon neutrality by 2025
waste reduction programs
|
|
gptkbp:website
|
www.astrazeneca.com
|
|
gptkbp:bfsParent
|
gptkb:temple
|
|
gptkbp:bfsLayer
|
3
|